jueves, 15 de septiembre de 2016

AHRQ Chartbook Tracks Progress of Prevention and Treatment Practices

AHRQ Chartbook Tracks Progress of Prevention and Treatment Practices

AHRQ--Agency for Healthcare Research and Quality: Advancing Excellence in Health Care



AHRQ's new Chartbook on Effective Treatment provides updated information about national efforts to improve prevention and treatment of eight health conditions that are leading causes of mortality and morbidity: cardiovascular disease, cancer, chronic kidney disease, diabetes, HIV and AIDS, mental health and substance abuse, musculoskeletal diseases, and respiratory diseases.  Among the highlights:

  • Performance measures for cardiovascular disease indicated that from 2000 to 2012, the percentage of adults with hypertension who had their blood pressure under control improved from about 30 percent to more than 50 percent.
  • Between 2001 and 2013, the percentage of diabetes-related hospital admissions decreased more for blacks (from about 88 percent to 45 percent) than for whites (from about 18 percent to 10 percent)
  •  From 2008 to 2013, the annual rate of HIV diagnoses declined by 9 percent, but the progress was uneven across different groups.  In 2011, 14 percent of people with HIV are unaware of their infection.
  • Among problem areas shown through performance measures:  increasing suicide deaths for both sexes and all racial groups; a lower percentage of adults with diagnosed diabetes who had their feet checked for sores or irritation; and a lower percentage of adults with asthma taking preventive medicine daily or almost daily. 
This chartbook is part of a family of documents and tools that support the National Healthcare Quality and Disparities Report and 5th Anniversary Update on the National Quality Strategy. That report provides an overview of the quality of U.S. health care as well as disparities in care for various racial, ethnic and socioeconomic groups.

To access AHRQ’s Chartbook on Effective Treatment, please visit https://goo.gl/j4nPVi.

No hay comentarios: